Facebook
Linkedin
Mail
Twitter
Youtube
Home
Latest News
Features
Interventional Oncology
Profiles
Media
Videos
Podcasts
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
Twitter
Youtube
Interventional News
Home
Latest News
Features
Interventional Oncology
Profiles
Media
Videos
Podcasts
Events
Supplements
Past Issues
Subscribe
Tag: gem
Boston Scientific announces acquisition of Obsidio
15th August 2022
Boston Scientific has announced the acquisition of Obsidio, a privately held company that has developed the Gel Embolic Material (GEM) technology used for embolization...